EdwardG.EvantashMD

PubMed

• 2 citations
  Vaginal Fetal Fibronectin to Predict Spontaneous Preterm Birth.
  Edward Evantash> ;JAMA. 2017 Jul 11
• 3 citations
  Vesico-uterine fistula after endometrial ablation in a woman with prior cesarean deliveries.
  Edward Evantash> ;Obstetrics and Gynecology. 2010 Apr 1
• 3 citations
  Clinical performance characteristics of the adiana® system for permanent contraception: the first year of commercial use.
  Seth J Herbst, Edward G Evantash> ;Reviews in Obstetrics & Gynecology. 2010 Jan 1
• 18 citations
  Prophylactic antibiotics for non-laboring patients with intact membranes undergoing cesarean delivery: an economic analysis.
  David Chelmow, Michael Hennesy, Edward G. Evantash> ;American Journal of Obstetrics and Gynecology. 2004 Nov 1
• 22 citations
  Myomectomy fever: testing the dogma
  Ronald E. Iverson, David Chelmow, Kris Strohbehn, Lisa Waldman, Edward G. Evantash, Michael P. Aronson> ;Fertility and Sterility. 1999 Jul 1
• 92 citations
  Relative morbidity of abdominal hysterectomy and myomectomy for management of uterine leiomyomas.
  Ronald E. Iverson, David Chelmow, Kris Strohbehn, Lisa Waldman, Edward G. Evantash> ;Obstetrics and Gynecology. 1996 Sep 1
• Immunomodulatory mechanisms of arginine.
  Reynolds, J. V., Daly, J. M., Zhang, S., Evantash, E., Shou, J., Sigal, R., Ziegler, M. M.> ;Surgery. 1988 Aug
• Prevention and treatment of osteoporosis.
  Evantash, E. G., Kawada, C. Y.> ;Compr Ther. 1994
• Join now to see all

Journal Articles

• Clinical Performance Characteristics of the Adiana System for Permanent Contraception: the first year of commercial use  
  Herbst SJ, Evantash EG, Rev Obstet Gynecol, 1/1/2010
• Myomectomy Fever: Confirming the Dogma  
  Iverson RE, Chelmow DC, Strohbehn K, Waldman L Evantash EG, Ronson MP, Fertil Steril, 1/1/1999
• Laparoscopic Sterilization Reversal  
  Cohen MA, Evantash E, Infertility and Reproductive Clinics of North America, 7/1/1997
• Laparoscopy in the Management of Pelvic Adhesions  
  Evantash E, Infertility and Reproductive Clinics of North America, 7/1/1997
• Prevention and Treatment of Osteoporosis  
  Evantash E, Kawada C, Comprehensive Therapy, 1/1/1994
• L-Arginine Potentiates Lymphokine Activated Killer (LAK) Cell Cytotoxicity  
  Lieberman MD, Sigal RK, Evantash E, Daly JM, FASEB J, 1/1/1990
• Immunomodulatory Mechanism of Arginine  
  Reynolds JV, Daly JM, Zhang S, Evantash E, Shou J, Sigal R, Ziegler MM, Surgery, 1/1/1988
• Upregulation of MHC Class I: Effect on Growth and LAK Sensitivity of Neuroblastoma  
  Sigal RK, Reynolds JV, Markmann JF, Shou J, Evantash E, Ziegler M, Naji A, Daly J, Surgical Forum, 1/1/1988
• Join now to see all

Books/Book Chapters

• Current Obstetric and Gynecologic Diagnosis and Treatment. 
  Chapter: Benign Disorders of the Uterine Cervix. 
  Evantash E, Hill EC, Pernoll MLMcGraw Hill2003
• Laparoscopy vs Laparotomy; Is There an Advantage. 
  Chapter: Introduction 
  Evantash E, DeCherney AHWilliams & Wilkins1994

Abstracts/Posters

• Endometrial Ablation Following Hysteroscopic Sterilization: Reports from the EASE Trial.
  Herbst SJ, Evantash EG, ACOG, 3/1/2011
• Thermal Analysis of an Adiana Procedure ona Concomitant and Subsequent NovaSure Procedure.
  Martin GT, Abele CC, Evantash EG, ACOG, 3/1/2011
• The 1-Year Estimated Efficacy Rate of the Adiana Permanent Contraception System in Community Use.
  Anderson TL, Evantash EG, J Minim Invasive Gynecol, 1/1/2011
• Electrical and Thermal Properties of a Novel Radiopaque Implant for the Adiana Permanent Contraception System.
  Martin GT, Evantash EG, J Minim Invasive Gynecol, 1/1/2011
• Evaluating Inter-Observer Variability on Hysterosalpingogram.
  Sakhel K, Evantash EG, J Minim Invasive Gynecol, 1/1/2011
• Evaluation of the Adiana Matrix during Concomitant NovaSure Endometrial Ablation.
  MacBride DM, Martin GT, Layton RK, Evantash E, J Minim Invasive Gynecol, 1/1/2010
• Severe dysplasia and adenocarcinoma in situ within an endocervical polyp.
  Navarro P, Moliner M, O’Brian J, Evantash E, Arch of Pathol Lab Med, 1/1/2009
• Cost Effectiveness of Prophylactic Antibiotic Administration for Low Risk Cesarean Delivery.
  Evantash E, Hennesey M, Chelmow D, Society Gynecologic Investigation, 11/1/2002
• Myomectomy Fever: Confirming the Dogma.
  Iverson RE, Chelmow D, Strohbehn, Walden L, Evantash EG, Aronson MP, Society for Gynecologic Surgeons, Orlando, FL, 3/1/1998
• Immunologic and Endocrinologic Effects of Major Abdominal Operations.
  Reynolds JV, Evantash E, Sigal R, Daly J, Tripartite Meeting, Bristol, United Kingdom, 7/1/1988
• Immune Stimulation Using Arginine: Correlation of In-Vivo and In-Vitro Effects in Man.
  Daly JM, Evantash E, Reynolds J, Shou J, Sigal R, Philadelphia Academy of Surgeons, 1/1/1988
• Join now to see all

Lectures

• Sunshine Act Compliance – Best Practices for Medical Device Companies. (Panelist) 
  10/2/2012
• The Evaluation and Treatment of Patients with Abnormal Uterine Bleeding. 
  Saints Memorial Hospital, Lowell, MA - 10/30/2008
• Update on the Management of Abnormal Uterine Bleeding. 
  Long Island College Hospital, Brooklyn, NY - 2/9/2007
• Endometrial Ablation and the Management of Abnormal Uterine Bleeding 
  Vassar Brothers Hospital, Poughkeepsie, NY - 7/19/2006
• Endometrial Ablation and the Management of Abnormal Uterine Bleeding. 
  Boston Medical Center, Boston, MA - 5/17/2006
• Management of the Abnormal Pap Smear. 
  Tufts University School of Medicine, Boston, MA - 4/1/2000
• Hysteroscopy and Endometrial Ablation. 
  New England Medical Center, Boston, MA - 11/1/1999
• Operative Hysteroscopy. 
  Beth Israel Deaconess Medical Center, Boston, MA - 4/1/1999
• Pelvic Pain: Diagnosis and Management 
  Leominster General Hospital, Leominster, MA - 1/1/1997
• Join now to see all